Orchestra BioMed Holdings, Inc.
USD4.59
-0.15 (-3.26%)
CEO
David Hochman
IPO Date
2020-08-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.74
Prev. Close
$4.75
Day Low
$4.54
Day High
$4.79
52W Low
$2.20
52W High
$5.42
Market Cap
$0.28B
Volume
0.14M
| -2.4 |
| 31 Dec 2023 | FY | 93.3% | -1779.7% | -72.2% | -51.6% | 0.02 | 7.95 | -6.2 |
| 31 Dec 2022 | FY | 90.9% | -951.3% | -64.0% | -35.2% | 0.23 | 4.56 | -7.6 |
| 31 Dec 2021 | FY | 125.4% | 2943.0% | 32.3% | -170.1% | -0.08 | 0.92 | -9.0 |
| 31 Dec 2020 | FY | 97.5% | -374.5% | 44.0% | -56.1% | -0.19 | 2.52 | -12.3 |
| 6.4 |
| 30 Sept 2025 | Q3 | 94.3% | -2419.0% | -47.6% | -19.9% | 0.37 | 4.73 | -1.1 |
| 30 Jun 2025 | Q2 | 94.5% | -2316.1% | -6563.7% | -45.2% | 55.44 | 2.10 | -1.3 |
| 31 Mar 2025 | Q1 | 94.9% | -2160.7% | -111.3% | -31.8% | 0.98 | 3.35 | -2.2 |
| 31 Dec 2024 | Q4 | 77.1% | -6385.4% | -49.0% | -21.2% | 0.50 | 4.27 | -2.4 |
| 30 Sept 2024 | Q3 | 93.1% | -1562.9% | -33.4% | -20.5% | 0.04 | 4.23 | -3.1 |
| 30 Jun 2024 | Q2 | 94.3% | -2054.0% | -36.2% | -22.1% | 0.03 | 4.58 | -4.0 |
| 31 Mar 2024 | Q1 | 82.6% | -2171.5% | -23.5% | -16.3% | 0.03 | 7.34 | -3.3 |
| 31 Dec 2023 | Q4 | 68.3% | -4892.4% | -18.8% | -13.5% | 0.02 | 7.95 | -6.4 |